Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.535 USD | -8.63% |
|
-7.93% | -79.03% |
May. 16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
May. 16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-79.03% | 65.73M | |
+18.73% | 125B | |
+13.69% | 108B | |
-7.30% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-14.10% | 16.37B | |
+2.37% | 13.58B | |
+27.88% | 11.66B |
- Stock Market
- Equities
- AEON Stock
- News AEON Biopharma, Inc.
- Sector Update: Health Care Stocks Mixed Late Afternoon